Cargando…
Use of Intravenous Immunoglobulins in Sepsis Therapy—A Clinical View
Sepsis is a life-threatening organ dysfunction, defined by a dysregulated host immune response to infection. During sepsis, the finely tuned system of immunity, inflammation and anti-inflammation is disturbed in a variety of ways. Both pro-inflammatory and anti-inflammatory pathways are upregulated,...
Autores principales: | Jarczak, Dominik, Kluge, Stefan, Nierhaus, Axel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7432410/ https://www.ncbi.nlm.nih.gov/pubmed/32756325 http://dx.doi.org/10.3390/ijms21155543 |
Ejemplares similares
-
Sepsis—Pathophysiology and Therapeutic Concepts
por: Jarczak, Dominik, et al.
Publicado: (2021) -
Cytokine Storm—Definition, Causes, and Implications
por: Jarczak, Dominik, et al.
Publicado: (2022) -
Best-practice IgM- and IgA-enriched immunoglobulin use in patients with sepsis
por: Nierhaus, Axel, et al.
Publicado: (2020) -
Chronic Critical Illness in Patients with COVID-19: Characteristics and Outcome of Prolonged Intensive Care Therapy
por: Roedl, Kevin, et al.
Publicado: (2022) -
The original sins of clinical trials with intravenous immunoglobulins in sepsis
por: Almansa, Raquel, et al.
Publicado: (2015)